A Toll-receptor map underlies structural brain plasticity.
D. melanogaster
Drosophila
MyD88
Toll
Yorkie
adul progenitor cells
adult neurogenesis
brain
critical period
neurodegeneration
neuron
neuronal activity
neuroscience
quiescence
structural plasticity
wek
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
18 02 2020
18 02 2020
Historique:
received:
14
10
2019
accepted:
12
02
2020
pubmed:
19
2
2020
medline:
27
4
2021
entrez:
19
2
2020
Statut:
epublish
Résumé
Experience alters brain structure, but the underlying mechanism remained unknown. Structural plasticity reveals that brain function is encoded in generative changes to cells that compete with destructive processes driving neurodegeneration. At an adult critical period, experience increases fiber number and brain size in Everything that you experience leaves its mark on your brain. When you learn something new, the neurons involved in the learning episode grow new projections and form new connections. Your brain may even produce new neurons. Physical exercise can induce similar changes, as can taking antidepressants. By contrast, stress, depression, ageing and disease can have the opposite effect, triggering neurons to break down and even die. The ability of the brain to change in response to experience is known as structural plasticity, and it is in a tug-of-war with processes that drive neurodegeneration. Structural plasticity occurs in other species too: for example, it was described in the fruit fly more than a quarter of a century ago. Yet, the molecular mechanisms underlying structural plasticity remain unclear. Li et al. now show that, in fruit flies, this plasticity involves Toll receptors, a family of proteins present in the brain but best known for their role in the immune system. Fruit flies have nine different Toll receptors, the most abundant being Toll-2. When activated, these proteins can trigger a series of molecular events in a cell. Li et al. show that increasing the amount of Toll-2 in the fly brain makes the brain produce new neurons. Activating neurons in a brain region has the same effect, and this increase in neuron number also depends on Toll-2. By contrast, reducing the amount of Toll-2 causes neurons to lose their projections and connections, and to die, and impairs fly behaviour. Li et al. also show that each Toll receptor has a unique distribution across the fly brain. Different types of experiences activate different brain regions, and therefore different Toll receptors. These go on to trigger a common molecular cascade, but they modulate it such as to result in distinct outcomes. By working together in different combinations, Toll receptors can promote either the death or survival of neurons, and they can also drive specific brain cells to remain dormant or to produce new neurons. By revealing how experience changes the brain, Li et al. provide clues to the way neurons work and form; these findings may also help to find new treatments for disorders that change brain structure, such as certain psychiatric conditions. Toll-like receptors in humans could thus represent a promising new target for drug discovery.
Autres résumés
Type: plain-language-summary
(eng)
Everything that you experience leaves its mark on your brain. When you learn something new, the neurons involved in the learning episode grow new projections and form new connections. Your brain may even produce new neurons. Physical exercise can induce similar changes, as can taking antidepressants. By contrast, stress, depression, ageing and disease can have the opposite effect, triggering neurons to break down and even die. The ability of the brain to change in response to experience is known as structural plasticity, and it is in a tug-of-war with processes that drive neurodegeneration. Structural plasticity occurs in other species too: for example, it was described in the fruit fly more than a quarter of a century ago. Yet, the molecular mechanisms underlying structural plasticity remain unclear. Li et al. now show that, in fruit flies, this plasticity involves Toll receptors, a family of proteins present in the brain but best known for their role in the immune system. Fruit flies have nine different Toll receptors, the most abundant being Toll-2. When activated, these proteins can trigger a series of molecular events in a cell. Li et al. show that increasing the amount of Toll-2 in the fly brain makes the brain produce new neurons. Activating neurons in a brain region has the same effect, and this increase in neuron number also depends on Toll-2. By contrast, reducing the amount of Toll-2 causes neurons to lose their projections and connections, and to die, and impairs fly behaviour. Li et al. also show that each Toll receptor has a unique distribution across the fly brain. Different types of experiences activate different brain regions, and therefore different Toll receptors. These go on to trigger a common molecular cascade, but they modulate it such as to result in distinct outcomes. By working together in different combinations, Toll receptors can promote either the death or survival of neurons, and they can also drive specific brain cells to remain dormant or to produce new neurons. By revealing how experience changes the brain, Li et al. provide clues to the way neurons work and form; these findings may also help to find new treatments for disorders that change brain structure, such as certain psychiatric conditions. Toll-like receptors in humans could thus represent a promising new target for drug discovery.
Identifiants
pubmed: 32066523
doi: 10.7554/eLife.52743
pii: 52743
pmc: PMC7077983
doi:
pii:
Substances chimiques
Toll-Like Receptors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P004997/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R017034/1
Pays : United Kingdom
Informations de copyright
© 2020, Li et al.
Déclaration de conflit d'intérêts
GL, MF, JW, ID, RW, NA, MP, RJ, JH, NS, MH, AH No competing interests declared
Références
J Neurosci. 1993 May;13(5):1852-61
pubmed: 8478679
Nat Immunol. 2006 Oct;7(10):1074-81
pubmed: 16964262
Nat Rev Neurosci. 2009 Sep;10(9):647-58
pubmed: 19693029
J Neurosci. 2007 Nov 21;27(47):13033-41
pubmed: 18032677
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15625-30
pubmed: 20713712
Development. 1994 Apr;120(4):885-99
pubmed: 7600965
Curr Opin Neurobiol. 2017 Dec;47:188-195
pubmed: 29145015
Elife. 2018 Apr 19;7:
pubmed: 29671739
J Comp Neurol. 1996 Jul 22;371(2):300-10
pubmed: 8835734
J Vis Exp. 2013 Apr 24;(74):e50339
pubmed: 23644755
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):5846-5853
pubmed: 28584125
J Exp Med. 2007 Sep 3;204(9):2063-74
pubmed: 17724133
Nat Rev Neurosci. 2010 May;11(5):339-50
pubmed: 20354534
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2967-76
pubmed: 25002478
Mol Pain. 2018 Jan-Dec;14:1744806918812636
pubmed: 30355052
PLoS Genet. 2017 Aug 28;13(8):e1006968
pubmed: 28846707
Dev Biol. 1992 Jan;149(1):134-48
pubmed: 1728583
Cell. 2018 Jul 26;174(3):622-635.e13
pubmed: 29909983
Dev Biol. 2015 Jul 15;403(2):162-71
pubmed: 25967126
J Neurochem. 2010 Jul;114(2):462-74
pubmed: 20456021
Nat Methods. 2011 Sep;8(9):737-43
pubmed: 21985007
J Neurosci. 1995 Mar;15(3 Pt 1):1951-60
pubmed: 7891144
J Neurosci. 1997 Feb 15;17(4):1493-504
pubmed: 9006990
PLoS One. 2015 Jul 13;10(7):e0132793
pubmed: 26167685
Nat Rev Genet. 2008 Mar;9(3):165-78
pubmed: 18227810
Cell Rep. 2013 Jun 27;3(6):1857-65
pubmed: 23791523
Nature. 2008 Oct 16;455(7215):894-902
pubmed: 18923511
Nat Rev Neurosci. 2016 Aug;17(8):497-511
pubmed: 27277867
J Neurosci. 2008 Dec 17;28(51):13978-84
pubmed: 19091986
Front Neurosci. 2016 Feb 16;10:33
pubmed: 26909014
Trends Neurosci. 2011 May;34(5):269-81
pubmed: 21419501
PLoS One. 2013 Oct 04;8(10):e75902
pubmed: 24124519
Sci Rep. 2016 Jun 17;6:28188
pubmed: 27312666
Nat Rev Neurosci. 2005 Aug;6(8):603-14
pubmed: 16062169
Development. 2009 Jan;136(1):51-9
pubmed: 19019992
Curr Biol. 2015 Mar 30;25(7):955-63
pubmed: 25754635
Nat Neurosci. 2013 Sep;16(9):1248-56
pubmed: 23892553
PLoS Biol. 2008 Nov 18;6(11):e284
pubmed: 19018662
Cell Rep. 2018 May 1;23(5):1491-1503
pubmed: 29719260
Cell. 1989 Apr 7;57(1):177-87
pubmed: 2702688
Curr Biol. 2018 May 21;28(10):1651-1660.e4
pubmed: 29754899
Curr Protoc Mol Biol. 2015 Jul 01;111:31.2.1-31.2.20
pubmed: 26131852
Nat Cell Biol. 2007 Sep;9(9):1081-8
pubmed: 17704767
Learn Mem. 1997 Jul-Aug;4(2):219-29
pubmed: 10456065
J Neurobiol. 2001 Feb 5;46(2):73-88
pubmed: 11153010
Front Neurosci. 2017 Jun 08;11:327
pubmed: 28642678
Development. 2018 Apr 25;145(9):
pubmed: 29695493
PLoS One. 2012;7(10):e47522
pubmed: 23071817
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18028-33
pubmed: 20921412
J Immunol. 2011 Jun 1;186(11):6417-26
pubmed: 21515789
J Cell Biol. 2017 May 1;216(5):1421-1438
pubmed: 28373203
Curr Biol. 2010 Apr 13;20(7):643-8
pubmed: 20346676
Development. 2018 Mar 8;145(5):
pubmed: 29440303
PLoS Biol. 2011 Aug;9(8):e1001133
pubmed: 21912512
Trends Immunol. 2012 Jul;33(7):333-42
pubmed: 22521509
Dev Biol. 2017 Dec 15;432(2):203-214
pubmed: 29080790
Curr Biol. 2018 Jun 4;28(11):1756-1767.e6
pubmed: 29804808
J Cell Biol. 2018 Aug 6;217(8):2727-2742
pubmed: 29777026
Cell Rep. 2014 Apr 24;7(2):588-598
pubmed: 24726363
Brain Behav Immun. 2015 Aug;48:301-12
pubmed: 26021559
Brain Res Rev. 2009 Mar;59(2):278-92
pubmed: 18822314
Dev Biol. 2018 Apr 1;436(1):28-41
pubmed: 29447906
J Cell Biol. 2006 Oct 23;175(2):209-15
pubmed: 17060494
Elife. 2017 Aug 25;6:
pubmed: 28841136
J Microsc. 2012 May;246(2):202-12
pubmed: 22429405
Cell. 2018 Aug 9;174(4):982-998.e20
pubmed: 29909982
Cell. 2005 Aug 12;122(3):421-34
pubmed: 16096061
Cell. 2008 May 30;133(5):891-902
pubmed: 18510932
EMBO J. 2017 May 2;36(9):1215-1226
pubmed: 28320737
Neuroscience. 2016 Jun 2;324:1-10
pubmed: 26955780
J Neurogenet. 1984 Apr;1(2):113-26
pubmed: 6085635
J Cell Biol. 2016 Aug 15;214(4):459-74
pubmed: 27502486
Front Cell Neurosci. 2018 Oct 02;12:329
pubmed: 30333729
Development. 2013 Dec;140(23):4818-25
pubmed: 24154526
J Immunol. 2015 Nov 15;195(10):4913-21
pubmed: 26423149
Genetics. 2007 Mar;175(3):1505-31
pubmed: 17194782
Dev Cell. 2013 May 28;25(4):388-401
pubmed: 23725764
Neural Dev. 2018 Jul 1;13(1):14
pubmed: 29960596
Cell. 2016 Jan 28;164(3):406-19
pubmed: 26824654
Development. 2017 Dec 15;144(24):4552-4562
pubmed: 29158446